Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.
The vertically integrated healthcare model across insurance, PBM, pharmacy, and clinical care capabilities underscores CVS Health's multi-year margin recovery prospects. This strategy has driven the better patient outcomes, superior membership retention, moderating medical benefit ratios, and robust revenue/margin expansion. Recent selloff has unlocked a cheaper P/E of 11.78x, along with the dual return prospects across capital appreciation to my LTPT of $129.90 and dividend yield of 2.84%.
| Health Care Providers & Services Industry | Healthcare Sector | J. David Joyner CEO | XETRA Exchange | US1266501006 ISIN |
| US Country | 259,500 Employees | 23 Jul 2026 Last Dividend | 7 Jun 2005 Last Split | 17 Dec 1984 IPO Date |
CVS Health Corporation is a leading provider of health solutions in the United States, with a comprehensive portfolio that spans across Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness sectors. As an integral part of the healthcare ecosystem, CVS Health offers a broad range of products and services designed to meet the needs of various stakeholders, including employers, individuals, health plans, and governmental entities. Initially named CVS Caremark Corporation, the company underwent a rebranding to CVS Health Corporation in September 2014, emphasizing its broadened focus on health and wellness. Founded in 1996 and headquartered in Woonsocket, Rhode Island, CVS Health has grown into a cornerstone of the American healthcare industry, continually evolving to address the complex challenges of modern healthcare.
CVS Health Corporation offers a diversified array of healthcare products and services, categorized into three main segments: